DIAPRIDE M1 (Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg))

Diapride M1 Tablet is classified as an anti-diabetic agent and is utilized for the management of type 2 diabetes in adults. This medication combines multiple compounds to effectively assist in regulating blood glucose levels among individuals diagnosed with diabetes. It is recommended to administer Diapride M1 Tablet in conjunction with or directly before meals for optimal effectiveness. Consistency in timing is key, so it is advisable to take this medication at the same time each day. The prescribing physician will determine the appropriate dosage tailored to individual needs, which may require adjustments over time based on glucose monitoring results. Continuing the treatment is essential, even if one’s condition appears stable or blood sugar levels are under control. Abrupt cessation without medical guidance can lead to elevated blood sugar levels, increasing the risk of severe complications such as kidney damage, vision loss, neuropathy, and amputations. This medication is part of a broader diabetes management strategy that incorporates a nutritious diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle modifications are crucial in achieving effective diabetes control and overall health improvement.
Recognizing the symptoms of hypoglycemia, such as excessive sweating, dizziness, headaches, and trembling is vital, as is knowing how to treat these episodes. Regular meal consumption can help mitigate these risks, and it is wise to have a rapid source of glucose, like candy or juice, readily available. Alcohol consumption can heighten the risk of hypoglycemia and should therefore be avoided while taking this medication. Other potential adverse effects may include alterations in taste, gastrointestinal disturbances, headaches, swelling, blurred vision, bone injuries, and respiratory infections. Some users may experience weight gain as a side effect of this treatment.